Cite
HARVARD Citation
Pollack, C. et al. (2015). INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS. Emergency medicine journal. 32 (12), pp. 979-980. [Online].